Description: ProSomnus is the first manufacturer of precision, mass-customized Precision Oral Appliance Therapy devices to treat OSA, which affects over 74 million Americans and is associated with serious comorbidities, including heart failure, stroke, hypertension, morbid obesity and type 2 diabetes. ProSomnus’ patented devices are a more comfortable and less invasive alternative to Continuous Positive Airway Pressure (CPAP) therapy, and lead to more effective and patient-preferred outcomes. With more than 150,000 patients treated, ProSomnus’ devices are the most prescribed Precision Oral Appliance Therapy in the U.S.
Home Page: www.prosomnus.com
OSA Technical Analysis
5675 Gibraltar Drive
Pleasanton,
CA
94588
United States
Phone:
844 537 5337
Officers
| Name | Title |
|---|---|
| Mr. Leonard Liptak | Co-Founder, CEO & Director |
| Mr. Sung Kim | Co-Founder & CTO |
| Ms. Laing F. Rikkers | Co-founder & Executive Chairman |
| Mr. Brian B. Dow | CFO & Corporate Secretary |
| Dr. John E. Remmers M.D. | Chief Scientist |
| Ms. Heather Whalen | Vice President of Global Marketing Services |
| Dr. Shouresh Charkhandeh D.D.S. | Global Scientific Committee Chair |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0.2956 |
| IPO Date: | 2021-07-28 |
| Fiscal Year End: | December |
| Full Time Employees: | 136 |